Showing 172,981 - 173,000 results of 260,524 for search '(( 0 ((0 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (nn decrease)) ))', query time: 2.38s Refine Results
  1. 172981

    Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists by Dehui Zhang (1332363)

    Published 2021
    “…Several OX2R agonists have been reported but with little or no activity at OX1R. We conducted structure–activity relationship studies on the OX2R agonist YNT-185 (<b>2</b>) and discovered dual agonists such as RTOXA-43 (<b>40</b>) with EC<sub>50</sub>’s of 24 nM at both OX2R and OX1R. …”
  2. 172982

    Chemotherapy Drug Induced Discoordination of Mitochondrial Life Cycle Detected by Cardiolipin Fluctuation by Yu-Jen Chao (665872)

    Published 2016
    “…<div><p>Chemotherapy drugs have been prescribed for the systemic treatment of cancer. We selected three chemotherapy drugs, including methotrexate, mitomycine C and vincristine to inhibit the proliferation of HT1080 human fibrosarcoma cells in S, G2 and M phases of the cell cycle respectively. …”
  3. 172983

    Data_Sheet_1_Public Database-Driven Insights Into Aging Stress-Associated Defective Gut Barrier With Low SARS-CoV-2 Receptors.PDF by Yuseok Moon (4877827)

    Published 2020
    “…In the present study, we assessed aging-associated gut transcriptomic responses considering the gastrointestinal symptoms contributing to COVID-19 severity. …”
  4. 172984

    Particle Imaging Velocimetry Evaluation of Intracranial Stents in Sidewall Aneurysm: Hemodynamic Transition Related to the Stent Design by Pierre Bouillot (668911)

    Published 2014
    “…<div><p>We investigated the flow modifications induced by a large panel of commercial-off-the-shelf (COTS) intracranial stents in an idealized sidewall intracranial aneurysm (IA). …”
  5. 172985

    Alterations in Hippocampal Oxidative Stress, Expression of AMPA Receptor GluR2 Subunit and Associated Spatial Memory Loss by <i>Bacopa monnieri</i> Extract (CDRI-08) in Streptozoto... by Surya P. Pandey (768295)

    Published 2015
    “…However, the precise molecular mechanism of the role of CDRI-08, a well characterized fraction of <i>Bacopa monnieri</i> extract, in recovery of the diabetes mellitus-induced memory impairments is not known. Here, we demonstrate that DM2 mice treated orally with lower dose of CDRI-08 (50- or 100 mg/kg BW) is able to significantly enhance spatial memory in STZ-DM2 mice and this is correlated with a significant decline in oxidative stress and up regulation of the AMPA receptor GluR2 subunit gene expression in the hippocampus. …”
  6. 172986

    Reappraisal of the Trophic Ecology of One of the World’s Most Threatened Spheniscids, the African Penguin by Maëlle Connan (680842)

    Published 2016
    “…These represent over 50% of the world population. Various samples (blood, feathers, egg membranes) were collected for carbon and nitrogen stable isotope analyses. …”
  7. 172987

    Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists by Dehui Zhang (1332363)

    Published 2021
    “…Several OX2R agonists have been reported but with little or no activity at OX1R. We conducted structure–activity relationship studies on the OX2R agonist YNT-185 (<b>2</b>) and discovered dual agonists such as RTOXA-43 (<b>40</b>) with EC<sub>50</sub>’s of 24 nM at both OX2R and OX1R. …”
  8. 172988

    Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists by Dehui Zhang (1332363)

    Published 2021
    “…Several OX2R agonists have been reported but with little or no activity at OX1R. We conducted structure–activity relationship studies on the OX2R agonist YNT-185 (<b>2</b>) and discovered dual agonists such as RTOXA-43 (<b>40</b>) with EC<sub>50</sub>’s of 24 nM at both OX2R and OX1R. …”
  9. 172989

    Data_Sheet_1_Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies.PDF by Fuwei Liu (4447765)

    Published 2021
    “…For the effectiveness outcomes, the use of DOACs compared with VKAs use was significantly associated with decreased risks of stroke or systemic embolism (RR = 0.66, 95% CI: 0.54–0.80) and venous thromboembolism (RR = 0.40, 95% CI: 0.26–0.61), but not ischemic stroke (RR = 0.79, 95% CI: 0.56–1.11), myocardial infarction (RR = 0.78, 95% CI: 0.56–1.11), cardiovascular death (RR = 0.76, 95% CI: 0.53–1.09), and all-cause death (RR = 0.82, 95% CI: 0.43–1.56). …”
  10. 172990

    Fatty acid qualitative profile in <i>Symbiodinium</i> cells submitted or not to seawater acidification. by Lilian J. Hill (7134752)

    Published 2019
    “…The decrease of species number was evident in the acidified condition after 16 days (T4), in comparison to T0 and T4 of control condition.…”
  11. 172991

    Chill-coma recovery time of <i>Bicyclus anynana</i> in relation to hardening temperature. by Klaus Fischer (82645)

    Published 2013
    “…<p>We predicted that colder hardening temperatures increase but warmer hardening temperatures decrease cold resistance. While hardening temperature indeed affected recovery time (F<sub>4,229</sub> = 3.08, p = 0.0169), both high and low hardening temperatures increased recovery times (6°C = 34°C≥13°C = 27°C (control) ≥20°C; Tukey HSD after ANOVA). …”
  12. 172992

    Correlation between metabolites and brain damage. by Matthias Keller (150331)

    Published 2011
    “…Light grey corresponds to metabolites that were not found to be significant at FDR0.1.</p>…”
  13. 172993
  14. 172994
  15. 172995
  16. 172996
  17. 172997
  18. 172998
  19. 172999
  20. 173000